Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Systemic Therapy”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Large-scale testing (Phase 3)Study completedNCT00567554
What this trial is testing

Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 2,600
Large-scale testing (Phase 3)Active Not RecruitingNCT01996267
What this trial is testing

Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2

Who this might be right for
Breast CancerHER2 Positive
The Netherlands Cancer Institute 437
Early research (Phase 1)WithdrawnNCT03477864
What this trial is testing

Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer

Who this might be right for
Stage III Prostate CancerStage IIIA Prostate CancerStage IIIB Prostate Cancer+4 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Post-approval studies (Phase 4)Ended earlyNCT05583188
What this trial is testing

Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC

Who this might be right for
NSCLC
Galvanize Therapeutics, Inc. 5
Not applicableNot Yet RecruitingNCT05131893
What this trial is testing

Neoadjuvant Treatment of Breast Cancer

Who this might be right for
Breast Cancer
National Institute of Oncology, Hungary 300
Not applicableEnrolling By InvitationNCT04195503
What this trial is testing

Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
University Health Network, Toronto 10
Testing effectiveness (Phase 2)WithdrawnNCT02850874
What this trial is testing

HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsPancreatic Adenocarcinoma
Wake Forest University Health Sciences
Not applicableActive Not RecruitingNCT05985551
What this trial is testing

Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment

Who this might be right for
Breast CancerChemotherapy EffectSentinel Lymph Node
Uppsala University 114
Large-scale testing (Phase 3)Study completedNCT00268567
What this trial is testing

Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone

Who this might be right for
Nephritis, Lupus
Peking University
Not applicableStudy completedNCT05779982
What this trial is testing

SURPASS Retrospective Study

Who this might be right for
Breast CancerBreast MRINeoadjuvant Systemic Therapy+1 more
Gangnam Severance Hospital 500
Not applicableLooking for participantsNCT07106112
What this trial is testing

Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Saint Petersburg State University, Russia 110
Post-approval studies (Phase 4)Study completedNCT02645565
What this trial is testing

Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Jawaharlal Institute of Postgraduate Medical Education & Research 75
Not applicableLooking for participantsNCT04486495
What this trial is testing

Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer

Who this might be right for
Breast CancerNeoadjuvant TherapyLymph Node Metastases
Maastricht University Medical Center 549
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05318794
What this trial is testing

Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer

Who this might be right for
Gastric CancerPeritoneal MetastasesChemotherapy Effect
Imperial College London 20
Not applicableActive Not RecruitingNCT05169853
What this trial is testing

Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerHER2-positive Breast Cancer
Ain Shams University 80
Not applicableStudy completedNCT03429816
What this trial is testing

OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma

Who this might be right for
Gastric NeoplasmGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma+2 more
University Hospital Heidelberg 120
Not applicableStudy completedNCT03437837
What this trial is testing

Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China

Who this might be right for
Breast CancerNeoadjuvant TherapyNeoplasm Staging+5 more
Peking University First Hospital 1,077
Not applicableStudy completedNCT06149377
What this trial is testing

Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer

Who this might be right for
Breast CancerSentinel Lymph Node
Fujian Medical University Union Hospital 716
Not applicableLooking for participantsNCT04703244
What this trial is testing

Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer

Who this might be right for
Breast CancerResidual
Mayo Clinic 999
Testing effectiveness (Phase 2)UnknownNCT00954135
What this trial is testing

Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients

Who this might be right for
Breast Cancer
University of Turin, Italy 190
Load More Results